277例糖尿病足感染病原微生物分布及耐药性分析

刘佳为; 王渊; 徐静; 王敏; 张春林; 童强

doi:10.16016/j.2097-0927.202405104

您当前的位置：

首页 >

文章列表页 >

277例糖尿病足感染病原微生物分布及耐药性分析

临床医学 | 更新时间：2026-01-09

- 277例糖尿病足感染病原微生物分布及耐药性分析
- Distribution and antimicrobial resistance in 277 cases with diabetic foot infection
- 陆军军医大学学报 2024年46卷第23期页码：2655-2660
- 作者机构：
  
  400037 重庆，陆军军医大学第二附属医院内分泌科
- 作者简介：
  
  [ 童强，E-mail：tq237366315@163.comTONG Qiang, E-mail: tq237366315@163.com
- 基金信息：
- DOI：10.16016/j.2097-0927.202405104
  中图分类号： R372;R587.2;R915
- 收稿：2024-05-28，
  
  修回：2024-08-08，
  
  纸质出版：2024-12-15
- 稿件说明：
移动端阅览
刘佳为, 王渊, 徐静, 等. 277例糖尿病足感染病原微生物分布及耐药性分析[J]. 陆军军医大学学报, 2024,46(23):2655-2660.

Jiawei LIU, Yuan WANG, Jing XU, et al. Distribution and antimicrobial resistance in 277 cases with diabetic foot infection[J]. Journal of Army Medical University, 2024, 46(23): 2655-2660.
刘佳为, 王渊, 徐静, 等. 277例糖尿病足感染病原微生物分布及耐药性分析[J]. 陆军军医大学学报, 2024,46(23):2655-2660. DOI： 10.16016/j.2097-0927.202405104.

Jiawei LIU, Yuan WANG, Jing XU, et al. Distribution and antimicrobial resistance in 277 cases with diabetic foot infection[J]. Journal of Army Medical University, 2024, 46(23): 2655-2660. DOI： 10.16016/j.2097-0927.202405104.

摘要

目的

分析糖尿病足感染病原微生物分布和耐药情况。

方法

以横断面调查形式统计2020年1月至2023年1月间我科277例住院糖尿病足患者的病历资料，记录其基本情况、创面特征、病原菌和耐药类型，统计分析病原菌分布、耐药率和多重耐药菌感染的危险因素。

结果

在277例患者中共培养出病原微生物228株，包括革兰阳性菌104株，革兰阴性菌115株，真菌7株，放线菌2株。革兰阴性菌在Wagner分级＞3级和溃疡病程＞30 d的患者中所占比例显著增加。革兰阳性菌对青霉素、红霉素耐药率较高，对万古霉素、利奈唑胺最敏感；革兰阴性菌对三、四代头孢菌素耐药率较低，对碳青霉烯类抗生素最敏感。Wagner分级＞3级和溃疡病程＞30 d是多重耐药菌感染的独立危险因素。

结论

糖尿病足感染病原微生物分布存在异质性，Wagner分级＞3级和病程＞30 d的病例以革兰阴性菌感染率高，多重耐药菌感染风险高，应及时针对性调整治疗方案。

Abstract

Objective

To analyze the distribution and antimicrobial resistance in diabetic foot infection.

Methods

A cross-section survey was conducted on 277 patients with diabetic foot infection admitted in our hospital between January 2020 and January 2023. Their clinical data were collected

and wound characteristics

pathogenic bacteria and drug resistance were analyzed statistically for the distribution of pathogenic bacteria

drug resistance rate

and risk factors for multidrug-resistant bacterial infections.

Results

There were 228 strains of pathogenic microorganisms isolated from the 277 patients

including 104 strains of Gram-positive bacteria

115 strains of Gram-negative bacteria

7 strains of fungi

and 2 strains of actinomycetes. The proportion of Gram-negative bacteria was significantly larger in the patients with Wagner grade >3 and course of ulcers >30 d. The isolated Gram-positive bacteria were highly resistant to penicillin and erythromycin

and most of them were sensitive to vancomycin and linezolid. While the Gram-negative ones were highly resistant to the third- and fourth-generation cephalosporins

and most sensitive to carbapenems. Wagner grade >3 and course of ulcers >30 d were independent risk factors for infection of multidrug-resistant organisms.

Conclusion

There is heterogeneity in the distribution of pathogenic microorganisms in diabetic foot infection. For the patients with Wagner grade >3 and course of ulcers >30 d

they have higher rate of Gram-negative bacterial infection

and are at higher risk of multidrug-resistant bacterial infection

so timely and targeted adjustment should be implemented for their treatment regimens.

关键词

Keywords

references

中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4): 315-409. DOI: 10.3760/cma.j.cn115791-20210221-00095.

Chinese Diabetes Society of Chinese Medical Association. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition) [J]. Chin J Diabetes Mellit, 2021, 13(4): 315-409. DOI: 10.3760/cma.j.cn115791-20210221-00095.

SEN P, DEMIRDAL T, EMIR B. Meta-analysis of risk factors for amputation in diabetic foot infections[J]. Diabetes Metab Res Rev, 2019, 35(7): e3165. DOI: 10.1002/dmrr.3165.

中华医学会糖尿病学分会, 中华医学会感染病学分会, 中华医学会组织修复与再生分会. 中国糖尿病足防治指南(2019版)(Ⅰ)[J]. 中华糖尿病杂志, 2019, 11(2): 92-108. DOI: 10.3760/cma.j.issn.1674-5809.2019.02.004.

Diabetes Society, Society of Infectious Diseases, Society for Tissue Repair and Regeneration of Chinese Medical Association. Chinese guideline on prevention and management of diabetic foot (2019 edition)(Ⅰ)[J]. Chin J Diabetes Mellit, 2019, 11(2): 92-108. DOI: 10.3760/cma.j.issn.1674-5809.2019.02.004.

ALBERTI K G, ZIMMET P Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med, 1998, 15(7): 539-553. DOI: 10.1002/(SICI)1096-9136(199807)15:7<539:AID-DIA668>3.0.CO;2-S.

VAN NETTEN J J, BUS S A, APELQVIST J, et al . Definitions and criteria for diabetic foot disease[J ] . Diabetes Metab Res Rev, 2020, 36(Suppl 1): e3268. DOI: 10.1002/dmrr.3268.

MAGIORAKOS A P, SRINIVASAN A, CAREY R B, et al . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance[J ] . Clin Microbiol Infect, 2012, 18(3): 268-281. DOI: 10.1111/j.1469-0691.2011.03570.x.

YEFOU M D, JINGI A M, ETOGA M C E, et al . Bacterial profile of diabetic foot infections and antibiotic susceptibility in a specialized diabetes centre in Cameroon[J ] . Pan Afr Med J, 2022, 42: 52. DOI: 10.11604/pamj.2022.42.52.31042.

AL-JOUFI F A, ALJARALLAH K M, HAGRAS S A, et al . Correction to: Microbial spectrum, antibiotic susceptibility profile, and biofilm formation of diabetic foot infections (2014-18): a retrospective multicenter analysis[J ] . 3 Biotech, 2021, 11(9): 419. DOI: 10.1007/s13205-021-02965-8.

DU F, MA J, GONG H P, et al . Microbial infection and antibiotic susceptibility of diabetic foot ulcer in China: literature review[J ] . Front Endocrinol, 2022, 13: 881659. DOI: 10.3389/fendo.2022.881659.

WU M X, PAN H, LENG W L, et al . Distribution of microbes and drug susceptibility in patients with diabetic foot infections in Southwest China[J ] . J Diabetes Res, 2018, 2018: 9817308. DOI: 10.1155/2018/9817308.

杨若梅, 周晴, 李英莎, 等. 重庆地区286例糖尿病足感染患者的病原菌特征、耐药性及代谢因素分析[J]. 第三军医大学学报, 2020, 42(13): 1331-1337. DOI: 10.16016/j.1000-5404.202002199.

YANG R M, ZHOU Q, LI Y S, et al . Distribution, antibiotic resistance and metabolic factors of pathogenic bacteria in diabetic foot infection: an analysis based on 286 patients in Chongqing[J ] . J Third Mil Med Univ, 2020, 42(13): 1331-1337. DOI: 10.16016/j.1000-5404.202002199.

ÁLVARO-AFONSO F J, GARCÍA-ÁLVAREZ Y, TARDÁGUILA-GARCÍA A, et al . Bacterial diversity and antibiotic resistance in patients with diabetic foot osteomyelitis[J ] . Antibiotics, 2023, 12(2): 212. DOI: 10.3390/antibiotics12020212.

LIPSKY B A, SENNEVILLE É, ABBAS Z G, et al . Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)[J ] . Diabetes Metab Res Rev, 2020, 36(Suppl 1): e3280. DOI: 10.1002/dmrr.3280.

中华医学会糖尿病学分会糖尿病足与周围血管病学组. 中国糖尿病足诊治临床路径(2023版)[J]. 中华内分泌代谢杂志, 2023, 39(2): 93-102. DOI: 10.3760/cma.j.cn311282-20221014-00583.

Group of Diabetic Foot and Peripheral Vascular Disease of Diabetes Society of Chinese Medical Association. Clinical pathway for the management of diabetic foot in China(2023 edition)[J]. Chin J Endocrinol Metab, 2023, 39(2): 93-102. DOI: 10.3760/cma.j.cn311282-20221014-00583.

LIU W, SONG L Y, SUN W, et al . Distribution of microbes and antimicrobial susceptibility in patients with diabetic foot infections in South China[J ] . Front Endocrinol, 2023, 14: 1113622. DOI: 10.3389/fendo.2023.1113622.

NORDMANN P, POIREL L. Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria[J]. Clin Infect Dis, 2019, 69(Supplement_7): S521-S528. DOI: 10.1093/cid/ciz824.

PITOCCO D, SPANU T, DI LEO M, et al . Diabetic foot infections: a comprehensive overview[J ] . Eur Rev Med Pharmacol Sci, 2019, 23(2 Suppl): 26-37. DOI: 10.26355/eurrev_201904_17471.

LIU L, LI Z H, LIU X X, et al . Bacterial distribution, changes of drug susceptibility and clinical characteristics in patients with diabetic foot infection[J ] . Exp Ther Med, 2018, 16(4): 3094-3098. DOI: 10.3892/etm.2018.6530.

毛敏婕, 王蔚, 周强, 等. 糖尿病足病原微生物多元化分布及耐药性分析[J]. 中国卫生检验杂志, 2021, 31(14): 1694-1698.

MAO M J, WANG W, ZHOU Q, et al . Diversity distribution and drug resistance analysis of pathogenic microorganism of diabetic foot[J ] . Chin J Health Lab Technol, 2021, 31(14): 1694-1698.

沈秋燕, 林迪妮, 朱虹, 等. 糖尿病足合并感染患者754株病原菌分布及耐药性分析[J]. 中华医学杂志, 2014, 94(12): 889-894. DOI: 10.3760/cma.j.issn.0376-2491.2014.12.004.

SHEN Q Y, LIN D N, ZHU H, et al . Clinical distribution and antimicrobial resistance analysis of 754 pathogenic bacteria in diabe tic foot infection[J ] . Natl Med J China, 2014, 94(12): 889-894. DOI: 10.3760/cma.j.issn.0376-2491.2014.12.004.

JABBOUR J F, KANJ S S. Gram-negative skin and soft tissue infections[J]. Infect Dis Clin North Am, 2021, 35(1): 157-167. DOI: 10.1016/j.idc.2020.10.008.

TAMMA P D, COSGROVE S E, MARAGAKIS L L. Combination therapy for treatment of infections with gram-negative bacteria[J]. Clin Microbiol Rev, 2012, 25(3): 450-470. DOI: 10.1128/CMR.05041-11.

DATTA P, CHANDER J, GUPTA V, et al . Evaluation of various risk factors associated with multidrug-resistant organisms isolated from diabetic foot ulcer patients[J ] . J Lab Physicians, 2019, 11(1): 58-62. DOI: 10.4103/JLP.JLP_106_18.

GUO H H, SONG Q W, MEI S W, et al . Distribution of multidrug-resistant bacterial infections in diabetic foot ulcers and risk factors for drug resistance: a retrospective analysis[J ] . PeerJ, 2023, 11: e16162. DOI: 10.7717/peerj.16162.

XIA W, HE W W, LUO T T, et al . Risk factors for multidrug-resistant bacterial infections in patients with diabetic foot ulcers: a systematic review and meta-analy sis[J ] . Ann Palliat Med, 2021, 10(12): 12618-12630. DOI: 10.21037/apm-21-3406.

BANDYK D F. The diabetic foot: Pathophysiology, evaluation, and treatment[J]. Semin Vasc Surg, 2018, 31(2/3/4): 43-48. DOI: 10.1053/j.semvascsurg.2019.02.001.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

重庆地区286例糖尿病足感染患者的病原菌特征、耐药性及代谢因素分析

糖尿病足患者细菌感染特征及其与下肢血管病变程度的关系

缺氧诱导因子-1α纳米抑制剂的构建及在逆转结直肠癌细胞化疗耐药中的应用

沉默高迁移率族蛋白B1对胶质母细胞瘤细胞恶性生物学行为的抑制

开放楔形胫骨高位截骨术后感染的危险因素分析